Education
About Us
Working with TipRanks
Follow Us
Arcellx Inc (ACLX)
NASDAQ:ACLX
ACLX Analyst Ratings
Strong Buy
15 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ACLX Stock 12 Month Forecast
Average Price Target
$114.08
▲(102.77% Upside)
| Highest Price Target$134.00 | Average Price Target$114.08 | Lowest Price Target$93.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
William Blair
Reiterated
05/09/25
Piper Sandler
Reiterated
05/09/25
H.C. Wainwright
Reiterated
05/09/25
Bank of America Securities
Reiterated
05/08/25
Morgan Stanley
Reiterated
05/08/25
Canaccord Genuity
Reiterated
05/08/25
Leerink Partners
$104
Buy
84.86%
Upside
Reiterated
03/26/25
Analysts Are Bullish on These Healthcare Stocks: Illumina (ILMN), Arcellx Inc (ACLX)
Stifel Nicolaus
$122→$118
Buy
109.74%
Upside
Reiterated
03/03/25
Stifel Nicolaus Reaffirms Their Buy Rating on Arcellx Inc (ACLX)
Evercore ISI
$120
Buy
113.30%
Upside
Reiterated
02/28/25
Evercore ISI Reaffirms Their Buy Rating on Arcellx Inc (ACLX)We updated our model to reflect the company’s uneventful 4Q results released this afternoon. The three most important points from the PR incl 1) the next clinical update from the pivotal iMMagine-1 study are anticipated mid-year (likely in June at EHA or ASCO); 2) the company still anticipates an anito-cel launch in 2026; and 3) cash of $626M still provides runway into 2027. Reiterate Outperform.
Truist Financial
$134
Buy
138.18%
Upside
Reiterated
02/28/25
Truist Financial Keeps Their Buy Rating on Arcellx Inc (ACLX)
Unknown Analyst
Not Ranked
Guggenheim
$120
Buy
113.30%
Upside
Reiterated
02/28/25
Updating model and reiterating our Buy rating as we continue to see an opportunity for anito-cel to be a best-in-class, fast-follower CAR-T therapy and capture meaningful share in the MM market.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
Reiterated
05/09/25
Piper Sandler
Reiterated
05/09/25
H.C. Wainwright
Reiterated
05/09/25
Bank of America Securities
Reiterated
05/08/25
Morgan Stanley
Reiterated
05/08/25
Canaccord Genuity
Reiterated
05/08/25
Leerink Partners
$104
Buy
84.86%
Upside
Reiterated
03/26/25
Analysts Are Bullish on These Healthcare Stocks: Illumina (ILMN), Arcellx Inc (ACLX)
Stifel Nicolaus
$122→$118
Buy
109.74%
Upside
Reiterated
03/03/25
Stifel Nicolaus Reaffirms Their Buy Rating on Arcellx Inc (ACLX)
Evercore ISI
$120
Buy
113.30%
Upside
Reiterated
02/28/25
Evercore ISI Reaffirms Their Buy Rating on Arcellx Inc (ACLX)We updated our model to reflect the company’s uneventful 4Q results released this afternoon. The three most important points from the PR incl 1) the next clinical update from the pivotal iMMagine-1 study are anticipated mid-year (likely in June at EHA or ASCO); 2) the company still anticipates an anito-cel launch in 2026; and 3) cash of $626M still provides runway into 2027. Reiterate Outperform.
Truist Financial
$134
Buy
138.18%
Upside
Reiterated
02/28/25
Truist Financial Keeps Their Buy Rating on Arcellx Inc (ACLX)
Unknown Analyst
Not Ranked
Guggenheim
$120
Buy
113.30%
Upside
Reiterated
02/28/25
Updating model and reiterating our Buy rating as we continue to see an opportunity for anito-cel to be a best-in-class, fast-follower CAR-T therapy and capture meaningful share in the MM market.
Best Analysts Covering Arcellx Inc
Which Analyst Should I Follow If I Want to Buy ACLX and Sell After:
1 Month
xxx
Success Rate
9/12 ratings generated profit
Average Return
+5.19%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +5.19% per trade.
3 Months
xxx
Success Rate
9/13 ratings generated profit
Average Return
+14.02%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +14.02% per trade.
1 Year
Success Rate
13/16 ratings generated profit
Average Return
+44.28%
reiterated a buy rating 3 days ago
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 81.25% of your transactions generating a profit, with an average return of +44.28% per trade.
2 Years
xxx
Success Rate
14/18 ratings generated profit
Average Return
+117.33%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +117.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ACLX Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
4
15
16
14
10
Buy
34
17
3
4
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
38
32
19
18
14
Each month's total comprises the sum of three months' worth of ratings.
ACLX Financial Forecast
ACLX Stock Forecast FAQ
What is ACLX’s average 12-month price target, according to analysts?
Based on analyst ratings, Arcellx Inc’s 12-month average price target is 114.08.
What is ACLX’s upside potential, based on the analysts’ average price target?
Arcellx Inc has 102.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ACLX a Buy, Sell or Hold?
Arcellx Inc has a consensus rating of Strong Buy which is based on 15 buy ratings, 0 hold ratings and 0 sell ratings.
What is Arcellx Inc’s price target?
The average price target for Arcellx Inc is 114.08. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $134.00 ,the lowest forecast is $93.00. The average price target represents 102.77% Increase from the current price of $56.26.
The highest analyst price target is $134.00 ,the lowest forecast is $93.00. The average price target represents 102.77% Increase from the current price of $56.26.
What do analysts say about Arcellx Inc?
Arcellx Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of ACLX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.